Development asset linked to Dogwood Therapeutics in public FDA and regional records.
pharma · Chemotherapy Induced Neuropathic Pain · DWTX
Dogwood Therapeutics
Dogwood Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Company details
- Status
- Public
- HQ
- Alpharetta, USA
- Founded
- 2020
- Employees
- 9
- Programs
- 1
- Drugs
- 2
- Patents
- 7
Dogwood Therapeutics pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Dogwood Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Dogwood Therapeutics in public FDA and regional records.